...
zom-img

Zomedica Pharmaceuticals Corp, Common Stock

ZOM

NYSE MKT

$0.118

+$0

(0%)

1D
Industry: Pharmaceuticals Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$147.60M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
5.70M
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.06
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.12 L
$0.23 H
$0.118

About Zomedica Pharmaceuticals Corp, Common Stock

Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company offers diagnostic products comprising TRUFORMA Bulk Acoustic Wave point of care diagnostic platform; TRUVIEW, a digital cystoscopy platform that offers automated slide preparation within the instrument; and VetGuardian, a zero-touch vital signs remote monitoring system. It also provides therapeutic products, including PulseVet electrohydraulic shockwave therapy platform; and Assisi Loop line of products, including the Assisi Loop, Assisi Loop Lounge, and DentaLoop devices that treat pain and inflammation through delivery of targeted pulsed electromagnetic field focused energy. The company has collaboration agreements with Celsee, Inc. for the development and commercialization of liquid biopsy assays and related consumables for the detection of cancer in companion animals; and Seraph Biosciences, Inc. for the development of a novel pathogen detection system. The company was formerly known as Zomedica Pharmaceuticals Corp. and changed its name to Zomedica Corp. in October 2020. Zomedica Corp. is headquartered in Ann Arbor, Michigan. more

Industry: PharmaceuticalsSector: Health Care

Returns

Time FrameZOMSectorS&P500
1-Week Return-4.84%-2.06%-0.55%
1-Month Return-7.09%-1.92%2.72%
3-Month Return-7.81%-10.4%7.66%
6-Month Return-16.31%-4.6%10.15%
1-Year Return-38.86%4.06%27.53%
3-Year Return-66.29%1.94%32.31%
5-Year Return-63.35%36.48%89.2%
10-Year Return-85.77%97.46%194.59%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue-14.12K4.13M18.93M25.19M[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":0.06,"profit":true},{"date":"2021-12-31","value":16.41,"profit":true},{"date":"2022-12-31","value":75.16,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Cost of Revenue787.61K530.02K1.08M5.28M7.87M[{"date":"2019-12-31","value":10.01,"profit":true},{"date":"2020-12-31","value":6.74,"profit":true},{"date":"2021-12-31","value":13.71,"profit":true},{"date":"2022-12-31","value":67.08,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit(787.61K)(530.02K)3.05M13.65M17.32M[{"date":"2019-12-31","value":-4.55,"profit":false},{"date":"2020-12-31","value":-3.06,"profit":false},{"date":"2021-12-31","value":17.64,"profit":true},{"date":"2022-12-31","value":78.83,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Margin-(3752.62%)73.89%72.12%68.76%[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-5078.48,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":97.6,"profit":true},{"date":"2023-12-31","value":93.05,"profit":true}]
Operating Expenses19.78M16.76M24.43M35.58M48.91M[{"date":"2019-12-31","value":40.45,"profit":true},{"date":"2020-12-31","value":34.28,"profit":true},{"date":"2021-12-31","value":49.94,"profit":true},{"date":"2022-12-31","value":72.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(19.78M)(16.76M)(21.37M)(21.92M)(31.59M)[{"date":"2019-12-31","value":-1978432700,"profit":false},{"date":"2020-12-31","value":-1676497800,"profit":false},{"date":"2021-12-31","value":-2137399700,"profit":false},{"date":"2022-12-31","value":-2192300000,"profit":false},{"date":"2023-12-31","value":-3159200000,"profit":false}]
Total Non-Operating Income/Expense(18.07K)(114.68K)1.01M5.24M1.17M[{"date":"2019-12-31","value":-0.34,"profit":false},{"date":"2020-12-31","value":-2.19,"profit":false},{"date":"2021-12-31","value":19.25,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":22.32,"profit":true}]
Pre-Tax Income(19.78M)(16.91M)(20.72M)(19.38M)(35.86M)[{"date":"2019-12-31","value":-1978405400,"profit":false},{"date":"2020-12-31","value":-1691178400,"profit":false},{"date":"2021-12-31","value":-2071622400,"profit":false},{"date":"2022-12-31","value":-1938100000,"profit":false},{"date":"2023-12-31","value":-3586000000,"profit":false}]
Income Taxes38.08K9.33K(2.33M)(2.37M)(1.33M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":24.51,"profit":true},{"date":"2021-12-31","value":-6127.52,"profit":false},{"date":"2022-12-31","value":-6214.05,"profit":false},{"date":"2023-12-31","value":-3495.73,"profit":false}]
Income After Taxes(19.82M)(16.92M)(18.38M)(17.02M)(34.53M)[{"date":"2019-12-31","value":-1982212900,"profit":false},{"date":"2020-12-31","value":-1692111700,"profit":false},{"date":"2021-12-31","value":-1838317000,"profit":false},{"date":"2022-12-31","value":-1701500000,"profit":false},{"date":"2023-12-31","value":-3452900000,"profit":false}]
Income From Continuous Operations(19.78M)(16.91M)(18.38M)(17.02M)(14.93M)[{"date":"2019-12-31","value":-1978405400,"profit":false},{"date":"2020-12-31","value":-1691178400,"profit":false},{"date":"2021-12-31","value":-1838317000,"profit":false},{"date":"2022-12-31","value":-1701500000,"profit":false},{"date":"2023-12-31","value":-1493200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(19.82M)(16.92M)(18.38M)(17.02M)(34.53M)[{"date":"2019-12-31","value":-1982212900,"profit":false},{"date":"2020-12-31","value":-1692111700,"profit":false},{"date":"2021-12-31","value":-1838317000,"profit":false},{"date":"2022-12-31","value":-1701500000,"profit":false},{"date":"2023-12-31","value":-3452900000,"profit":false}]
EPS (Diluted)(0.20)(0.06)(0.05)(0.02)(0.03)[{"date":"2019-12-31","value":-20,"profit":false},{"date":"2020-12-31","value":-6,"profit":false},{"date":"2021-12-31","value":-5,"profit":false},{"date":"2022-12-31","value":-2.41,"profit":false},{"date":"2023-12-31","value":-3.1,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

ZOM
Cash Ratio 9.53
Current Ratio 10.82
Quick Ratio 10.15

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

ZOM
ROA (LTM) -9.29%
ROE (LTM) -23.92%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

ZOM
Debt Ratio Lower is generally better. Negative is bad. 0.05
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.95

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

ZOM
Trailing PE NM
Forward PE NM
P/S (TTM) 4.56
P/B 0.58
Price/FCF NM
EV/R 1.61
EV/Ebitda NM

FAQs

What is Zomedica Pharmaceuticals Corp share price today?

Zomedica Pharmaceuticals Corp (ZOM) share price today is $0.118

Can Indians buy Zomedica Pharmaceuticals Corp shares?

Yes, Indians can buy shares of Zomedica Pharmaceuticals Corp (ZOM) on Vested. To buy Zomedica Pharmaceuticals Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ZOM stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Zomedica Pharmaceuticals Corp be purchased?

Yes, you can purchase fractional shares of Zomedica Pharmaceuticals Corp (ZOM) via the Vested app. You can start investing in Zomedica Pharmaceuticals Corp (ZOM) with a minimum investment of $1.

How to invest in Zomedica Pharmaceuticals Corp shares from India?

You can invest in shares of Zomedica Pharmaceuticals Corp (ZOM) via Vested in three simple steps:

  • Click on Sign Up or Invest in ZOM stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Zomedica Pharmaceuticals Corp shares
What is Zomedica Pharmaceuticals Corp 52-week high and low stock price?

The 52-week high price of Zomedica Pharmaceuticals Corp (ZOM) is $0.23. The 52-week low price of Zomedica Pharmaceuticals Corp (ZOM) is $0.12.

What is Zomedica Pharmaceuticals Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Zomedica Pharmaceuticals Corp (ZOM) is

What is Zomedica Pharmaceuticals Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Zomedica Pharmaceuticals Corp (ZOM) is 0.58

What is Zomedica Pharmaceuticals Corp dividend yield?

The dividend yield of Zomedica Pharmaceuticals Corp (ZOM) is 0.00%

What is the Market Cap of Zomedica Pharmaceuticals Corp?

The market capitalization of Zomedica Pharmaceuticals Corp (ZOM) is $147.60M

What is Zomedica Pharmaceuticals Corp’s stock symbol?

The stock symbol (or ticker) of Zomedica Pharmaceuticals Corp is ZOM

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top